10 October 2024
Cambridge Cognition Holdings plc
("Cambridge Cognition", the "Company" or the "Group")
Block Listing Return
The Company makes the following notification pursuant to AIM Rule 29 and Schedule Six of the AIM Rules for Companies, regarding its existing block listings:
| Name of applicant: |
Cambridge Cognition Holdings plc |
|||
| Name of scheme: |
Share Options |
|||
| Period of return: |
From: |
1 April 2024 |
To: |
1 October 2024 |
| Number and class of share(s) (amount of stock / debt securities) originally listed and the date of admission: |
1,000,000 ordinary shares of £0.01 each in the Company admitted to trading on 23 March 2023 |
|||
| Balance of unallotted securities under scheme(s) from previous return: |
466,316 ordinary shares |
|||
| Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): |
Nil |
|||
| Less: Number of securities issued/allotted under scheme(s) during period: |
Nil |
|||
| Equals: Balance under scheme(s) not yet issued/allotted at end of period: |
466,316 ordinary shares |
|||
| Name of contact: |
Simon McKeating |
| Telephone number of contact: |
+44 (0)1223 810700 |
Enquiries:
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The Company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early and improve global efficiency in pharmaceutical and healthcare industries.
For further information visit: https://cambridgecognition.com/